Experimental Blood Cancer Immunotherapy Shows Survival Benefit in Late-Stage Trial
Sellas Life Sciences announced that its experimental immunotherapy, galinpepimut-S, met its primary endpoint in a Phase 3 trial by lowering the risk of death in acute myeloid leukemia patients.
🔬ResearchPhoto: statnews.com
Key points
- Galinpepimut-S reduced the risk of death by 41% in a Phase 3 trial.
- The study focused on patients with an advanced stage of acute myeloid leukemia.
- The outcome successfully achieved the primary goal outlined by Sellas Life Sciences.
Sellas Life Sciences reported that its experimental immunotherapy, galinpepimut-S, significantly decreased the risk of death by 41% compared to standard care for patients suffering from an advanced stage of acute myeloid leukemia. According to the company, this outcome successfully met the primary objective of the Phase 3 clinical trial.
While the findings suggest a potential advancement for treating this challenging form of blood cancer, experts note that detailed trial data and peer review are necessary to fully understand the clinical impact and potential limitations of the study. Observational and early-stage findings often require broader replication before changing standard medical practices.
What to know: The experimental treatment is designed to target specific cancer antigens, though patients should always consult their healthcare providers for personal medical guidance and treatment decisions.
Source statnews.com — statnews.com/2026/11/17/sellas-blood-cancer-immunotherapy-succeeds-… ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …
🧠Mind & Mental HealthNew Theoretical Framework Explores Memory Formation and Dementia
Researchers have proposed a new model suggesting the brain's limbic system functions similarly to generative AI, potentially offering a new way to understand and classify…